ESR1 and breast carcinoma: In the present study, we examined public gene expression datasets and report that although survivin expression is higher in estrogen receptor-negative (ER−) than estrogen-receptor-positive (ER+) breast cancer, it is only prognostic in ER+ breast cancer.